While substance P was elevated in the peripheral venous plasma of 42% (30/71) of CS patients, neurokinin A and neuropeptide K were elevated in 67% (14/21) and 75% (12/16) of CS patients, respectively (Table 1, row 5). The gene discussed is TAC1; the disease is Cowden syndrome 1.